- Home
- CRT vs GNTA Comparison
CRT vs GNTA Comparison
Compare CRT & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.42
Company Overview
Basic Information| Metric | CRT | GNTA |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.5M | 41.7M |
| IPO Year | 1992 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRT | GNTA |
|---|---|---|
| Price | $8.08 | $1.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.6K | ★ 122.9K |
| Earning Date | 03-12-2026 | 03-30-2026 |
| Dividend Yield | ★ 9.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $5,621,913.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.81 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.07 | $1.28 |
| 52 Week High | $13.31 | $10.00 |
Technical Indicators
Market Signals| Indicator | CRT | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 35.61 |
| Support Level | $7.34 | $1.28 |
| Resistance Level | $8.36 | $1.77 |
| Average True Range (ATR) | 0.34 | 0.18 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 48.03 | 22.78 |
Price Performance
Historical Comparison CRT
GNTA
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.